SGN-CD33A COMBINED WITH HYPOMETHYLATING THERAPY PRODUCES HIGH REMISSION RATES AMONG OLDER PATIENTS WITH AML

Dr Amir Fathi (Abstract S503):

   

KILLER ANTIBODIES AGAINST AML

Dr Mette Hazenberg (Abstract S124):

   

IMPROVED SURVIVAL FOR ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS

Dr Nina Toft (Abstract LB173):

   

THE CLOT THICKENS

Dr Katherine A High (Abstract LB771):

   

GENOME SEQUENCING OF THOUSANDS OF PATIENTS WITH RARE BLOOD DISORDERS

Dr Ernest Turro (Abstract S518):

   

Refugees in 2016 - new hematological challenges

 Dr Christine Chomienne, EHA President Elect: